Logo image of ELES.MI

ELES SEMICONDUCTOR EQUIPMENT (ELES.MI) Stock Fundamental Analysis

BIT:ELES - Euronext Milan - IT0005373417 - Common Stock - Currency: EUR

2.17  -0.08 (-3.56%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ELES. ELES was compared to 54 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and the financial health of ELES get a neutral evaluation. Nothing too spectacular is happening here. ELES is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

ELES had positive earnings in the past year.
ELES had a positive operating cash flow in the past year.
ELES had positive earnings in each of the past 5 years.
ELES had a positive operating cash flow in 4 of the past 5 years.
ELES.MI Yearly Net Income VS EBIT VS OCF VS FCFELES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

1.2 Ratios

ELES has a worse Return On Assets (2.24%) than 82.35% of its industry peers.
The Return On Equity of ELES (4.47%) is worse than 76.47% of its industry peers.
With a Return On Invested Capital value of 6.98%, ELES is not doing good in the industry: 60.78% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for ELES is significantly below the industry average of 16.29%.
The last Return On Invested Capital (6.98%) for ELES is above the 3 year average (4.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROIC 6.98%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ELES.MI Yearly ROA, ROE, ROICELES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ELES's Profit Margin of 3.48% is on the low side compared to the rest of the industry. ELES is outperformed by 82.35% of its industry peers.
In the last couple of years the Profit Margin of ELES has declined.
ELES has a worse Operating Margin (12.08%) than 64.71% of its industry peers.
In the last couple of years the Operating Margin of ELES has grown nicely.
ELES has a better Gross Margin (51.40%) than 72.55% of its industry peers.
In the last couple of years the Gross Margin of ELES has grown nicely.
Industry RankSector Rank
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
ELES.MI Yearly Profit, Operating, Gross MarginsELES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELES is destroying value.
The number of shares outstanding for ELES has been increased compared to 1 year ago.
ELES has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ELES has an improved debt to assets ratio.
ELES.MI Yearly Shares OutstandingELES.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ELES.MI Yearly Total Debt VS Total AssetsELES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ELES has an Altman-Z score of 2.40. This is not the best score and indicates that ELES is in the grey zone with still only limited risk for bankruptcy at the moment.
ELES's Altman-Z score of 2.40 is on the low side compared to the rest of the industry. ELES is outperformed by 74.51% of its industry peers.
ELES has a debt to FCF ratio of 2.75. This is a good value and a sign of high solvency as ELES would need 2.75 years to pay back of all of its debts.
ELES has a Debt to FCF ratio (2.75) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.34 indicates that ELES is not too dependend on debt financing.
ELES has a Debt to Equity ratio of 0.34. This is in the lower half of the industry: ELES underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Altman-Z 2.4
ROIC/WACC0.66
WACC10.54%
ELES.MI Yearly LT Debt VS Equity VS FCFELES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

ELES has a Current Ratio of 2.33. This indicates that ELES is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.33, ELES is in line with its industry, outperforming 49.02% of the companies in the same industry.
ELES has a Quick Ratio of 1.79. This is a normal value and indicates that ELES is financially healthy and should not expect problems in meeting its short term obligations.
ELES has a Quick ratio (1.79) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 1.79
ELES.MI Yearly Current Assets VS Current LiabilitesELES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

7

3. Growth

3.1 Past

ELES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.37%, which is quite impressive.
Measured over the past 5 years, ELES shows a small growth in Earnings Per Share. The EPS has been growing by 0.68% on average per year.
ELES shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.92%.
Measured over the past years, ELES shows a quite strong growth in Revenue. The Revenue has been growing by 15.31% on average per year.
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%

3.2 Future

Based on estimates for the next years, ELES will show a very strong growth in Earnings Per Share. The EPS will grow by 44.29% on average per year.
ELES is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.52% yearly.
EPS Next Y66.67%
EPS Next 2Y52.75%
EPS Next 3Y41.5%
EPS Next 5Y44.29%
Revenue Next Year14.17%
Revenue Next 2Y12.55%
Revenue Next 3Y10.52%
Revenue Next 5Y12.52%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ELES.MI Yearly Revenue VS EstimatesELES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M 50M
ELES.MI Yearly EPS VS EstimatesELES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.05 0.1 0.15 0.2 0.25

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

ELES is valuated quite expensively with a Price/Earnings ratio of 27.13.
The rest of the industry has a similar Price/Earnings ratio as ELES.
ELES's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.19.
The Price/Forward Earnings ratio is 21.27, which indicates a rather expensive current valuation of ELES.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELES is on the same level as its industry peers.
ELES's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.33.
Industry RankSector Rank
PE 27.13
Fwd PE 21.27
ELES.MI Price Earnings VS Forward Price EarningsELES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

90.20% of the companies in the same industry are more expensive than ELES, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ELES is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.31
EV/EBITDA 5.67
ELES.MI Per share dataELES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELES's earnings are expected to grow with 41.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)39.71
EPS Next 2Y52.75%
EPS Next 3Y41.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ELES!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELES SEMICONDUCTOR EQUIPMENT

BIT:ELES (7/15/2025, 7:00:00 PM)

2.17

-0.08 (-3.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.74%
Inst Owner ChangeN/A
Ins Owners31.74%
Ins Owner ChangeN/A
Market Cap37.30M
Analysts82.86
Price Target3.25 (49.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 27.13
Fwd PE 21.27
P/S 1.04
P/FCF 6.31
P/OCF 5.93
P/B 1.34
P/tB 2.07
EV/EBITDA 5.67
EPS(TTM)0.08
EY3.69%
EPS(NY)0.1
Fwd EY4.7%
FCF(TTM)0.34
FCFY15.84%
OCF(TTM)0.37
OCFY16.87%
SpS2.08
BVpS1.62
TBVpS1.05
PEG (NY)0.41
PEG (5Y)39.71
Profitability
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROCE 10.95%
ROIC 6.98%
ROICexc 9.24%
ROICexgc 13.76%
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
FCFM 16.55%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ROICexc(3y)6.24%
ROICexc(5y)5.97%
ROICexgc(3y)9.41%
ROICexgc(5y)8.84%
ROCE(3y)7.35%
ROCE(5y)6.52%
ROICexcg growth 3Y38.04%
ROICexcg growth 5Y10.61%
ROICexc growth 3Y34.42%
ROICexc growth 5Y9.58%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
F-Score9
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Debt/EBITDA 1.27
Cap/Depr 12.67%
Cap/Sales 1.08%
Interest Coverage 250
Cash Conversion 85.52%
Profit Quality 475.3%
Current Ratio 2.33
Quick Ratio 1.79
Altman-Z 2.4
F-Score9
WACC10.54%
ROIC/WACC0.66
Cap/Depr(3y)32.99%
Cap/Depr(5y)27.08%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
EPS Next Y66.67%
EPS Next 2Y52.75%
EPS Next 3Y41.5%
EPS Next 5Y44.29%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%
Revenue Next Year14.17%
Revenue Next 2Y12.55%
Revenue Next 3Y10.52%
Revenue Next 5Y12.52%
EBIT growth 1Y38.54%
EBIT growth 3Y59.16%
EBIT growth 5Y29.31%
EBIT Next Year200%
EBIT Next 3Y58.14%
EBIT Next 5Y50.77%
FCF growth 1Y269.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.26%
OCF growth 3YN/A
OCF growth 5YN/A